New Long-Acting
Treatment Option for
Schizophrenia
Now FDA approved
Schizophrenia Key Facts
What to know about schizophrenia, how common it is, and why relapse matters.
Understanding Schizophrenia
Explore the human impact, clinical challenges and importance of stability in care in schizophrenia.
What Lies Beneath
Uncovering the hidden drivers and impact of stigma in schizophrenia
"I thought my life was not redeemable. I didn't think my life was fixable."
Sarah Merritt Ryan opens up about her life with schizophrenia and her path to stability.
Sarah Merritt Ryan interview: Path to stability
"I thought my life was not redeemable. I didn't think my life was fixable. I thought everything was hopeless. But through patience and time, I healed." Sarah Merritt Ryan was 33 when she was diagnosed with schizophrenia - after three psychotic breaks in two years. She came home from the hospital with disability papers and a sense that the life she'd imagined was no longer available to her. Today, she is a wife, a mother, a writer and an advocate whose work shapes how psychiatry residents are trained. Her path to stability wasn't linear – it took time, hard lessons, and learning to make heart-led choices. Her story is a reminder of what's possible when we don't give up on people – and when people don't give up on themselves.
Living with Schizophrenia
Schizophrenia at Work: Facing Stigma and Finding a Way Forward
Confronting Schizophrenia Stigma: Overcoming Self-Shame, Stereotypes, and Media Myths
Diagnosed with Schizophrenia: What I Wish I’d Known Then
Embracing Authenticity: Disclosing My Schizophrenia, and the Peace it Brought Me
Reflecting on Your Past with Schizophrenia: Managing the What-Ifs
The Financial Impact of Schizophrenia: A Personal Perspective on Costs, Care, and Recovery
Psychosis Recovery: Learning to Trust the Process
Don’t Snooze, I Lose: How I’m Learning to Sleep with Schizophrenia
My Happy Book: Finding Comfort While Living with Schizoaffective Disorder
How Schizophrenia Guided My Career as a Clinical Social Worker
Stepping Up Innovation
Innovation for patients is at the heart of what we do, in every stage of drug development and delivery.
From in-house innovation to strategic partnerships, we are persistent in the creation of innovative medicines, generics and biologics to increase the accessibility and affordability of existing medicines.
Press Releases
Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
Healthy Future: Sustainability at Teva
Teva's Healthy Future Report: Creating the Future We Want to See
Our latest Healthy Future Report shows the steps Teva is taking for the health of people, the planet and our business.
Take a closer look at what we do
Understanding Schizophrenia: The Human Impact, the Clinical Challenges and the Importance of Stability in Care
Teva in Q2 2026: Our transformation at a glance
Teva in Q1 2026: Our transformation at a glance
4 Things You Might Not Know About Our 2025 Healthy Future Report
Sustaining Teva’s Generics Powerhouse in the Acceleration Phase
Step Up Innovation
Pivot to Growth: The Acceleration Phase
Delivering on Growth Engines
Teva in 2025: Innovation drives third consecutive year of growth
Supporting Healthier Communities
Careers at Teva
Make a difference to people's health, every day
Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves.
